STAAR Surgical designs, manufactures, and sells Implantable Collamer Lenses (ICLs), proprietary phakic intraocular lenses made from Collamer, a collagen copolymer material exclusive to the company. The company generates all revenue from ICL sales to ophthalmic surgeons, vision centers, hospitals, and distributors across more than 85 countries, with operations headquartered in California and manufacturing facilities in California and Switzerland. Patients typically fund ICL procedures out-of-pocket as elective refractive surgery, and STAAR positions its reversible lens implants as premium alternatives to laser-based procedures like LASIK, targeting the large and growing population with myopia globally.